Universal Vision Biotechnology Management
Management criteria checks 2/4
Universal Vision Biotechnology's CEO is Pi-Jung Lin, appointed in Jun 2001, has a tenure of 23.42 years. directly owns 22.75% of the company’s shares, worth NT$4.13B. The average tenure of the management team and the board of directors is 12.2 years and 6.4 years respectively.
Key information
Pi-Jung Lin
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 23.4yrs |
| CEO ownership | 22.7% |
| Management average tenure | 12.2yrs |
| Board average tenure | 6.4yrs |
Recent management updates
Recent updates
Universal Vision Biotechnology (GTSM:3218) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 03
The Case For Universal Vision Biotechnology Co., Ltd. (GTSM:3218): Could It Be A Nice Addition To Your Dividend Portfolio?
Mar 26Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Shares Could Be 39% Below Their Intrinsic Value Estimate
Mar 08The 22% Return On Capital At Universal Vision Biotechnology (GTSM:3218) Got Our Attention
Feb 07Universal Vision Biotechnology Co., Ltd. (GTSM:3218) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 17
Universal Vision Biotechnology (GTSM:3218) Seems To Use Debt Rather Sparingly
Dec 27Estimating The Fair Value Of Universal Vision Biotechnology Co., Ltd. (GTSM:3218)
Dec 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | NT$1b |
| Jun 30 2024 | n/a | n/a | NT$1b |
| Mar 31 2024 | n/a | n/a | NT$1b |
| Dec 31 2023 | n/a | n/a | NT$1b |
| Sep 30 2023 | n/a | n/a | NT$1b |
| Jun 30 2023 | n/a | n/a | NT$976m |
| Mar 31 2023 | n/a | n/a | NT$903m |
| Dec 31 2022 | n/a | n/a | NT$851m |
| Sep 30 2022 | n/a | n/a | NT$791m |
| Jun 30 2022 | n/a | n/a | NT$719m |
| Mar 31 2022 | n/a | n/a | NT$659m |
| Dec 31 2021 | NT$3m | NT$965k | NT$595m |
Compensation vs Market: Insufficient data to establish whether Pi-Jung's total compensation is reasonable compared to companies of similar size in the TW market.
Compensation vs Earnings: Insufficient data to compare Pi-Jung's compensation with company performance.
CEO
Pi-Jung Lin
23.4yrs
Tenure
NT$2,925,000
Compensation
Mr. Pi-Jung Lin serves as a Director of Universal Vision Biotechnology Co., Ltd. since June 2, 2003 and is its Chief Technology Officer since June 1, 2001. He is a Founder of Universal Vision Biotechnology...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 23.4yrs | NT$2.93m | 22.75% NT$ 4.1b | |
| Director of Finance & Accounting | 2.1yrs | no data | no data | |
| Director of Human Resources & Administration Division | 4.5yrs | no data | no data | |
| Director of Marketing Division | 12.2yrs | no data | no data | |
| Chief Auditor of Audit Office | 14.8yrs | no data | no data |
12.2yrs
Average Tenure
Experienced Management: 3218's management team is seasoned and experienced (12.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 21.4yrs | NT$2.93m | 22.75% NT$ 4.1b | |
| Director | less than a year | no data | no data | |
| Representative Chairman of Board | 12.4yrs | NT$4.09m | 3.87% NT$ 704.2m | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 12.4yrs | NT$2.05m | no data | |
| Independent Director | 6.4yrs | NT$2.05m | 0.014% NT$ 2.6m | |
| Independent Director | 3.3yrs | NT$951.00k | no data | |
| Representative Director | 6.4yrs | NT$1.90m | no data | |
| Representative Director | 6.4yrs | NT$1.90m | no data |
6.4yrs
Average Tenure
Experienced Board: 3218's board of directors are considered experienced (6.4 years average tenure).